Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

BGI Shenzhen Buys Complete Genomics of the US for $117 Million

publication date: Sep 17, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China’s BGI, the world’s largest sequencing company, paid $117 million to buy Complete Genomics, a California-based gene sequencing company. Complete Genomics owns a platform technology for sequencing whole human genomes. Although scientists appreciated the quality and completeness of Complete Genomics’ work, competitors could supply adequate amounts of information at a lower price. As a result, the company put itself up for sale at the beginning of the summer. By purchasing Complete Genomics, BGI has acquired another platform, and it has also extended its footprint in the US. More details....

Stock Symbol: (NSDQ: GNOM)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...